Revenue Growth Nearly Flat
Q3 FY2026 revenue came in at $1.670B, essentially unchanged (+0.1%) versus the prior-year period of $1.668B, suggesting limited volume or pricing growth across CLX's product portfolio during the quarter.
CLOROX CO /DE/ is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: CLX delivered essentially flat Q3 FY2026 results with revenue up just 0.1% to $1.67B and net income up 0.5% to $187M, while gross margin compressed 137 bps to 43.2% due to higher cost of revenue, and a large debt issuance dramatically reshaped the balance sheet, pushing stockholders' equity into negative territory.
Drawn from management commentary in the Q1 2026 10-Q:
Q3 FY2026 revenue came in at $1.670B, essentially unchanged (+0.1%) versus the prior-year period of $1.668B, suggesting limited volume or pricing growth across CLX's product portfolio during the quarter.
Cost of revenue rose 2.6% YoY to $948M while revenue was flat, compressing gross margin by approximately 137 basis points to 43.2% from 44.6%, indicating meaningful input cost or product mix headwinds.
SG&A expenses declined sharply by 14.2% YoY to $229M from $267M, a $38M reduction that helped offset gross profit erosion and supported net income growth of 0.5% to $187M.
Revenue
$1.67B
++0.12% YoY
EPS (Basic)
$1.54
++1.99% YoY
Gross Margin
43.2%
-1.37% YoY
Add CLX to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.